An Introduction to Ocular Oncology
Advanced research into genetics and cancer has revolutionised our understanding of conjunctival and uveal melanoma, but treatment remains challenging.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Ocular Oncology Content
Hans Grossniklaus, Association for Research in Vision and Ophthalmology: Presidential update 2023
The Association for Research in Vision and Ophthalmology (ARVO) is the largest and most respected eye and vision research organization in the world. Members include nearly 10,000 researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. In an insightful interview with touchOPHTHALMOLOGY, the […]
Basil K Williams, Hawaiian Eye 2022: Retinoblastoma and Uveal Melanoma
The field of ocular oncology is rapidly changing, according to a presentation at Hawaiian Eye 2022. It was a pleasure to speak with Dr Basil K Williams (University of Cincinnati, Cincinnati, OH, USA) on the topic of retinoblastoma and its challenges, and treatment options for uveal melanoma. The abstract entitled What’s New in the World […]
Basil K Williams, Hawaiian Eye 2022: Ocular Oncology – What’s New?
The field of ocular oncology is rapidly changing, according to a presentation at Hawaiian Eye 2022. We were delighted to speak with Dr Basil K Williams (University of Cincinnati, Cincinnati, OH, USA) about new developments in the field of ocular oncology. The abstract entitled What’s New in the World of Ocular Oncology? was presented at […]
Rumana Hussain, EURETINA 2021: Small High-risk Melanoma – Lower Mortality Rate
It was a pleasure to meet Rumana Hussain (Liverpool University Hospital, Liverpool, UK) to discuss the results of her study into the mortality risks of genetically high-risk uveal melanomas, and the implications for future treatment paradigms. Questions What is known about the mortality risks of genetically high-risk uveal melanomas (UM)? (00:20) What were the aims […]
Evaluation of Proptosis: A Primer
touchREVIEWS in Ophthalmology. 2021;15(1):26–32 DOI: https://doi.org/10.17925/OPHT.2021.15.1.26
An abnormal protrusion of the eyeball, beyond the boundaries of the bony orbit, is termed ‘proptosis’. A similar appearance, seen in endocrine dysfunction, especially thyroid disorders, is called ‘exophthalmos’. These conditions are frequently encountered in clinical practice, and for students, residents and trainees, the situation may prove rather challenging. This primer presents a concise blueprint […]
Clinical Features and Management of Eyelid Malignancies
US Ophthalmic Review. 2020;13(2):63-7 DOI: https://doi.org/10.17925/USOR.2020.13.2.63
The eyelids may harbor malignancies that can pose serious risks to the eyes. Some carcinomas can be life threatening or associated with distant metastasis. More commonly, failure to diagnose and treat in a timely manner can lead to local tumor growth, with possible direct extension to the adjacent ocular surface, orbit, or skull base. Late […]
Radiation Retinopathy—A Review of Past and Current Treatment Strategies
US Ophthalmic Review. 2020;13(1):34–9 DOI: https://doi.org/10.17925/USOR.2020.13.1.34
Radiation retinopathy is a common and slowly progressive visual side effect of radiation therapy, such as brachytherapy, external beam radiotherapy, proton beam radiation, helium ion radiotherapy, and gamma knife radiotherapy for uveal melanoma and other intraocular or orbital cancers.1–6 Patients treated with radiation therapy for cancers of the head and neck can also develop radiation-related […]
Antonia Joussen, EURETINA 2019 – Treating patients with large tumours
Antonia Joussen (Charité, University Medicine Berlin) shares her advice on preserving the eye when treating patients with large tumours and shares the key take-home messages of her presentations at EURETINA 2019. Questions: 1. How do you preserve eyes with large tumours? 2. What are the main take-home messages of your presentations at EURETINA 2019? Support: […]
Pearls for Treating Retinoblastoma
US Ophthalmic Review. 2018;11(2):79–80 DOI: https://doi.org/10.17925/USOR.2018.11.2.79
Retinoblastoma is a primary intraocular cancer that develops in the eyes of children. The vast majority of retinoblastoma tumorigenesis is initiated by a mutation in the RB1 gene on chromosome 13q,1 which was the first tumor-suppressor gene described. Retinoblastoma is a rare disease occurring in approximately one in 18,000 live births annually and can affect […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!